• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用正常模式分析准确预测 Akt pleckstrin 同源结构域的结合形式,以探索结构的灵活性。

Accurate prediction of the bound form of the Akt pleckstrin homology domain using normal mode analysis to explore structural flexibility.

机构信息

Department of Experimental Therapeutics, MD Anderson Cancer Center, Houston, Texas 77030, United States.

出版信息

J Chem Inf Model. 2011 Sep 26;51(9):2352-60. doi: 10.1021/ci2001742. Epub 2011 Aug 25.

DOI:10.1021/ci2001742
PMID:21834588
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3807676/
Abstract

Molecular docking is often performed with rigid receptors. This can be a serious limitation, since the receptor often differs between bound and unbound forms or between bound forms with different ligands. We recently developed a normal-mode based docking method and showed that it is possible to obtain reasonable estimates of the complexed form of the pleckstrin homology (PH) domain of Akt, starting with the free form of the receptor. With inositol (1,3,4,5)-tetrakisphosphate (IP4) as the ligand the docked results agree with the known high-resolution X-ray crystal structure of the IP4-Akt PH domain complex. We also tested our methods with PH4, SC66, and PIT-1, several recently designed PH domain inhibitors. The results are shown to be consistent with available experimental data and previous modeling studies. The method we described can be used for molecular docking analysis even when only an approximation of the experimental structure or model is known.

摘要

分子对接通常使用刚性受体进行。这可能是一个严重的限制,因为受体在结合和未结合形式之间或具有不同配体的结合形式之间通常会有所不同。我们最近开发了一种基于正常模式的对接方法,并表明可以从受体的自由形式开始,获得 Akt 的pleckstrin 同源(PH)结构域与配体结合的合理估计。使用肌醇(1,3,4,5)-四磷酸(IP4)作为配体,对接结果与已知的高分辨率 X 射线晶体结构 Akt PH 结构域复合物一致。我们还使用 PH4、SC66 和 PIT-1 等几种最近设计的 PH 结构域抑制剂对我们的方法进行了测试,结果与可用的实验数据和以前的建模研究一致。当仅知道实验结构或模型的近似值时,我们描述的方法也可用于分子对接分析。

相似文献

1
Accurate prediction of the bound form of the Akt pleckstrin homology domain using normal mode analysis to explore structural flexibility.利用正常模式分析准确预测 Akt pleckstrin 同源结构域的结合形式,以探索结构的灵活性。
J Chem Inf Model. 2011 Sep 26;51(9):2352-60. doi: 10.1021/ci2001742. Epub 2011 Aug 25.
2
In vitro and in vivo activity of novel small-molecule inhibitors targeting the pleckstrin homology domain of protein kinase B/AKT.靶向蛋白激酶B/AKT的普列克底物蛋白同源结构域的新型小分子抑制剂的体外和体内活性
Cancer Res. 2009 Jun 15;69(12):5073-81. doi: 10.1158/0008-5472.CAN-08-3839. Epub 2009 Jun 2.
3
High-resolution structure of the pleckstrin homology domain of protein kinase b/akt bound to phosphatidylinositol (3,4,5)-trisphosphate.与磷脂酰肌醇(3,4,5)-三磷酸结合的蛋白激酶b/akt的普列克底物蛋白同源结构域的高分辨率结构。
Curr Biol. 2002 Jul 23;12(14):1256-62. doi: 10.1016/s0960-9822(02)00972-7.
4
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.针对 Akt pleckstrin 同源结构域的新型抑制剂的计算建模。
Bioorg Med Chem. 2009 Oct 1;17(19):6983-92. doi: 10.1016/j.bmc.2009.08.022. Epub 2009 Aug 19.
5
Distinct specificity in the binding of inositol phosphates by pleckstrin homology domains of pleckstrin, RAC-protein kinase, diacylglycerol kinase and a new 130 kDa protein.普列克底物蛋白、RAC蛋白激酶、二酰基甘油激酶及一种新的130 kDa蛋白的普列克底物蛋白同源结构域对肌醇磷酸的结合具有明显特异性。
Biochim Biophys Acta. 1997 Dec 12;1359(3):275-85. doi: 10.1016/s0167-4889(97)00109-2.
6
Novel inhibitors of AKT: assessment of a different approach targeting the pleckstrin homology domain.新型 AKT 抑制剂:针对 pleckstrin 同源结构域的不同靶点评估。
Curr Med Chem. 2011;18(18):2727-42. doi: 10.2174/092986711796011292.
7
Specific inhibition of the Akt1 pleckstrin homology domain by D-3-deoxy-phosphatidyl-myo-inositol analogues.D-3-脱氧磷脂酰肌醇类似物对Akt1普列克底物蛋白同源结构域的特异性抑制作用。
Mol Cancer Ther. 2003 Apr;2(4):389-99.
8
Ca(2+)/calmodulin directly interacts with the pleckstrin homology domain of AKT1.钙离子/钙调蛋白直接与AKT1的普列克底物蛋白同源结构域相互作用。
J Biol Chem. 2007 Aug 24;282(34):25131-40. doi: 10.1074/jbc.M702123200. Epub 2007 Jun 19.
9
Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors.普列克底物蛋白同源结构域依赖性及同工酶特异性Akt抑制剂的鉴定与表征
Biochem J. 2005 Jan 15;385(Pt 2):399-408. doi: 10.1042/BJ20041140.
10
Selective cellular effects of overexpressed pleckstrin-homology domains that recognize PtdIns(3,4,5)P3 suggest their interaction with protein binding partners.识别磷脂酰肌醇-3,4,5-三磷酸(PtdIns(3,4,5)P3)的过表达普列克底物蛋白同源结构域的选择性细胞效应表明它们与蛋白质结合伴侣相互作用。
J Cell Sci. 2005 Oct 15;118(Pt 20):4879-88. doi: 10.1242/jcs.02606.

引用本文的文献

1
The therapeutic value of SC66 in human renal cell carcinoma cells.SC66 在人肾癌细胞中的治疗价值。
Cell Death Dis. 2020 May 11;11(5):353. doi: 10.1038/s41419-020-2566-1.
2
Novel insights of structure-based modeling for RNA-targeted drug discovery.基于结构的 RNA 靶向药物发现的新见解。
J Chem Inf Model. 2012 Oct 22;52(10):2741-53. doi: 10.1021/ci300320t. Epub 2012 Sep 21.
3
From laptop to benchtop to bedside: structure-based drug design on protein targets.从笔记本电脑到台式机再到床边:基于结构的药物设计针对蛋白质靶标。

本文引用的文献

1
GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation.GROMACS 4:高效、负载均衡和可扩展的分子模拟算法。
J Chem Theory Comput. 2008 Mar;4(3):435-47. doi: 10.1021/ct700301q.
2
Deactivation of Akt by a small molecule inhibitor targeting pleckstrin homology domain and facilitating Akt ubiquitination.小分子抑制剂靶向pleckstrin homology 结构域并促进 Akt 泛素化,从而使其失活。
Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6486-91. doi: 10.1073/pnas.1019062108. Epub 2011 Apr 4.
3
Development of sulfonamide AKT PH domain inhibitors.
Curr Pharm Des. 2012;18(9):1217-39. doi: 10.2174/138161212799436386.
磺酰胺类 AKT PH 结构域抑制剂的开发。
Bioorg Med Chem. 2011 Mar 15;19(6):2046-54. doi: 10.1016/j.bmc.2011.01.049. Epub 2011 Feb 1.
4
Recent development of anticancer therapeutics targeting Akt.针对 Akt 的抗癌治疗的最新进展。
Recent Pat Anticancer Drug Discov. 2011 Jan;6(1):146-59. doi: 10.2174/157489211793980079.
5
Small molecule inhibition of phosphatidylinositol-3,4,5-triphosphate (PIP3) binding to pleckstrin homology domains.小分子抑制磷脂酰肌醇-3,4,5-三磷酸(PIP3)与pleckstrin 同源结构域的结合。
Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):20126-31. doi: 10.1073/pnas.1004522107. Epub 2010 Nov 1.
6
HIV-1 TAR RNA spontaneously undergoes relevant apo-to-holo conformational transitions in molecular dynamics and constrained geometrical simulations.HIV-1 TAR RNA 能够在分子动力学和约束几何模拟中自发进行相关的 apo 到 holo 构象转变。
J Chem Inf Model. 2010 Aug 23;50(8):1489-501. doi: 10.1021/ci100101w.
7
Computational approaches for protein function prediction: a combined strategy from multiple sequence alignment to molecular docking-based virtual screening.蛋白质功能预测的计算方法:从多序列比对到基于分子对接的虚拟筛选的联合策略
Biochim Biophys Acta. 2010 Sep;1804(9):1695-712. doi: 10.1016/j.bbapap.2010.04.008. Epub 2010 Apr 28.
8
Ensemble docking into multiple crystallographically derived protein structures: an evaluation based on the statistical analysis of enrichments.基于富集分析的统计评估:多种晶体学衍生蛋白结构的整体对接
J Chem Inf Model. 2010 Apr 26;50(4):511-24. doi: 10.1021/ci900407c.
9
FiberDock: Flexible induced-fit backbone refinement in molecular docking.FiberDock:分子对接中的灵活诱导契合骨架精修。
Proteins. 2010 May 1;78(6):1503-19. doi: 10.1002/prot.22668.
10
Normal mode analysis of biomolecular structures: functional mechanisms of membrane proteins.生物分子结构的正常模式分析:膜蛋白的功能机制
Chem Rev. 2010 Mar 10;110(3):1463-97. doi: 10.1021/cr900095e.